Videos
Pharmacy Times spoke with Ron Lanton, Principal at Lanton Law, about Rutledge v. PCMA and its impact on pharmacy and PBMs.
This Pharmacy Times Webcast provides an overview of how the COVID-19 pandemic has impacted the treatment and management of patients with cancer.
Congress is in the middle of discussing this issue, Hogue said, meaning pharmacists need to advocate for provider status immediately.
Students at the University of the Sciences Philadelphia College of Pharmacy answered the questions “Are you able to work hands-on in any capacity? If so, what safety measures are being taken?” in interviews with Pharmacy TimesTM.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medetomidine: The Demon in the Illicit Fentanyl Supply
2
Higher-Valent Pneumococcal Conjugate Vaccines More Cost-Effective in Adult Populations
3
Study: Increased Serum cAMP Levels Observed in Patients With Asthma
4
HDL-C-to-LDL-C Ratio Can Predict Prognosis of High-Risk CVD Individuals
5
